Wall Street banks including Goldman Sachs Group Inc. and private credit lenders are lining up around €3.6 billion ($4.2 billion) of debt financing to back buyout firm GTCR’s acquisition of generic drugmaker Zentiva Group AS, according to people with knowledge of the matter.
